Oppenheimer analyst Ittai Kidron raised his price target for Alteryx to $85 from $65 after the company reported a strong Q4, roughly in line with its previously pre-announced results, highlighted by strong billings growth, year over year margin expansion, solid new customer growth, and impressive international expansion. While Alteryx continues to aggressively invest in its platform and go-to-market efforts, the analyst continues to believe it will drive further revenue upside, strong installed base expansion, and help the company maintain high growth rates for a longer period of time. Kidron reiterates an Outperform rating on the shares.